GL
Gaurav Luthra
About Gaurav Luthra
Data last updated:
Gaurav Luthra has 12 years in corporate governance. Holds Director and Designated Partner roles. Currently with 3 companies, including Auxein Medical Private Limited and Kaulmed Private Limited. Formerly with 2 companies, such as Ambey Fabtex Private Limited. Engaged in General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
 Auxein Medical Private Limited U33110DL2012PTC241539 | Director | 14 Mar 2014 | 2012 | Active |
 Vibronics Lab Private Limited U85300DL2020PTC364942 | Director | 17 Jun 2020 | 2020 | Active |
 Kaulmed Llp ACF-1848 | Designated Partner | 30 Jan 2024 | 2024 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
| Ambey Fabtex Private Limited U18204DL2010PTC202177 | Director | 26 Dec 2015 | 2010 | Active |
 Kaulmed Private Limited U33119DL2020PTC360048 | Director | 09 Jan 2020 | 2020 | Converted To Llp |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Gaurav Luthra
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gaurav Luthra
Gaurav Luthra has 12 years in corporate governance. Holds Director and Designated Partner roles. Currently with 3 companies, including Auxein Medical Private Limited and Kaulmed Private Limited. Formerly with 2 companies, such as Ambey Fabtex Private Limited. Engaged in General Business. Contributes to corporate operations.
Gaurav Luthra is associated with 3 companies as Director and Designated Partner.
Gaurav Luthra has expertise in General Business.
Gaurav Luthra has 12 years in corporate governance.